Ayr Wellness Inc.

OTC:AYRWF

2.15 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 117.284117.513118.009114.392116.737117.665124.622119.639110.131111.225111.76996.18991.25258.39847.76545.48628.31133.55332.28332.08810.8230.2260.2240.2430.2330.2280.025
Cost of Revenue 82.17879.1379.60366.26160.0969.38369.50270.12869.83665.70760.53256.10668.93833.93329.1544.7294.84113.28823.99717.7617.14000000
Gross Profit 35.10638.38338.40648.13156.64748.28255.1249.51140.29545.51951.23740.08322.31324.46518.61140.75723.4720.2648.28614.3263.6830.2260.2240.2430.2330.2280.025
Gross Profit Ratio 0.2990.3270.3250.4210.4850.410.4420.4140.3660.4090.4580.4170.2450.4190.390.8960.8290.6040.2570.4460.34111111
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 0000000050.37549.73349.20233.54831.18522.8113.21612.82817.14519.95419.62819.147.7341.5342.270.7330.1360.6086.81
Selling & Marketing Expenses 0000000001.8183.2671.9191.7710.7440.5640.6430.4090.5350.4630.5090.237000000
SG&A 41.73439.02341.05638.83346.92952.0567.18552.98150.37551.55152.46835.46732.95623.55413.77913.47117.55420.48820.09219.6497.9711.5342.270.7330.1360.6086.81
Other Expenses 0.6041.8-0.5486.303-3.51415.61414.77814.4413.99513.64383.7410.5250.491-0.0010.085-0.1410.0450.1160.1850.013-0.012-135.195-41.196-24.636-5.5610.4780.497
Operating Expenses 41.73439.02341.05650.74258.79667.66481.96367.42164.3765.19461.99847.98545.629.52118.618.04121.94524.88624.33824.0169.4981.5342.270.7330.1360.6086.81
Operating Income -6.629-0.64-2.65-1.451-4.5398.6593.137-16.227-22.363-19.646-13.859-8.9-24.881-8.368-2.05222.0141.029-4.873-16.898-10.734-5.583-1.308-2.045-0.4910.097-0.381-6.785
Operating Income Ratio -0.057-0.005-0.022-0.013-0.0390.0740.025-0.136-0.203-0.177-0.124-0.093-0.273-0.143-0.0430.4840.036-0.145-0.523-0.335-0.516-5.782-9.113-2.020.416-1.671-276.829
Total Other Income Expenses Net -17.845-95.779-18.4267.463-5.904-9.864-157.961-10.613-8.19621.7649.0919.02811.258-3.716-136.527-38.923-3.19311.722.45638.946-31.75-135.179-41.216-24.636-5.5610.4780.497
Income Before Tax -24.474-96.419-21.076-5.727-18.316-1.205-154.824-26.84-30.5592.11433.4146.627-16.092-11.64-138.551-17.077-2.5476.208-14.88627.94-38.014-136.487-43.261-25.127-5.4640.097-6.288
Income Before Tax Ratio -0.209-0.821-0.179-0.05-0.157-0.01-1.242-0.224-0.2770.0190.2990.069-0.176-0.199-2.901-0.375-0.090.185-0.4610.871-3.512-603.435-192.759-103.48-23.4810.426-256.551
Income Tax Expense 14.82411.43310.05313.54312.88711.17813.79210.5879.6911.3079.62810.0064.6464.9825.039.7164.9664.6532.5791.7590.498135.17941.21624.6365.561-0.478-0.497
Net Income -38.75-105.601-28.135-19.246-29.933-12.383-168.616-37.427-40.249-9.19323.786-3.379-20.738-16.622-143.581-26.793-7.5141.555-17.46426.181-38.512-136.487-43.261-25.127-5.4640.097-6.288
Net Income Ratio -0.33-0.899-0.238-0.168-0.256-0.105-1.353-0.313-0.365-0.0830.213-0.035-0.227-0.285-3.006-0.589-0.2650.046-0.5410.816-3.558-603.435-192.759-103.48-23.4810.426-256.551
EPS -0.34-1.08-0.37-0.25-0.41-0.18-2.43-0.54-0.59-0.140.4-0.057-0.36-0.38-3.26-0.96-0.280.058-0.650.99-2.34-36.93-11.7-6.8-1.480.026-8.93
EPS Diluted -0.34-1.08-0.37-0.25-0.41-0.18-2.43-0.54-0.59-0.140.4-0.057-0.36-0.38-3.26-0.89-0.280.058-0.590.84-2.34-36.92-11.7-6.8-1.480.026-8.93
EBITDA 16.93123.2520.09925.90416.32633.69628.4227.5170.2071.59494.7728.153-8.4592.2914.94327.0715.942-0.376-11.227-5.989-4.056133.87139.17124.1455.658-0.858-7.282
EBITDA Ratio 0.1440.1980.170.2260.140.2860.2280.0630.0020.0140.8480.085-0.0930.0390.1030.5950.21-0.011-0.348-0.187-0.375591.87174.53499.43924.314-3.769-297.108